Literature DB >> 30655824

Sirtuin 1 and oral cancer.

Shajedul Islam1, Yoshihiro Abiko2, Osamu Uehara1,3, Itsuo Chiba1.   

Abstract

The sirtuins (SIRTs) are a family of highly conserved histone deacetylases (HDACs) consisting of seven members (SIRT1-SIRT7). Over the past few decades, SIRT1 has been the most extensively studied and garnered tremendous attention in the scientific community due to its emerging role in cancer biology. However, its biological role in the regulation of oral cancer is not yet fully understood. Owing to contradictory findings regarding the role of SIRT1 in oral cancer, debate about it continues. The present study discusses the biological roles and potential therapeutic implications of SIRT1 in precancerous oral lesions and oral cancer.

Entities:  

Keywords:  betel quid; oral cancer; sirtuin; transforming growth factor beta

Year:  2018        PMID: 30655824      PMCID: PMC6313032          DOI: 10.3892/ol.2018.9722

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  14 in total

Review 1.  How Each Component of Betel Quid Is Involved in Oral Carcinogenesis: Mutual Interactions and Synergistic Effects with Other Carcinogens-a Review Article.

Authors:  Shajedul Islam; Malsantha Muthumala; Hirofumi Matsuoka; Osamu Uehara; Yasuhiro Kuramitsu; Itsuo Chiba; Yoshihiro Abiko
Journal:  Curr Oncol Rep       Date:  2019-04-26       Impact factor: 5.075

2.  Proteasome inhibitor induced SIRT1 deacetylates GLI2 to enhance hedgehog signaling activity and drug resistance in multiple myeloma.

Authors:  Ying Xie; Jing Liu; Hongmei Jiang; Jingya Wang; Xin Li; Jingjing Wang; Shuai Zhu; Jing Guo; Tao Li; Yuping Zhong; Qiguo Zhang; Zhiqiang Liu
Journal:  Oncogene       Date:  2019-10-01       Impact factor: 9.867

Review 3.  Understanding the significance of biological clock and its impact on cancer incidence.

Authors:  Shalie Malik; James Stokes Iii; Upender Manne; Rajesh Singh; Manoj K Mishra
Journal:  Cancer Lett       Date:  2021-12-11       Impact factor: 8.679

4.  The anti-tumour effect of induced pluripotent stem cells against submandibular gland carcinoma in rats is achieved via modulation of the apoptotic response and the expression of Sirt-1, TGF-β, and MALAT-1 in cancer cells.

Authors:  Eman Mohamed Faruk; Dina Sabry; Ahmed A Morsi; Yasmine Alaa El-Din; Neama M Taha; Engy Medhat
Journal:  Mol Cell Biochem       Date:  2021-09-17       Impact factor: 3.396

5.  MiR-29a function as tumor suppressor in cervical cancer by targeting SIRT1 and predict patient prognosis.

Authors:  Ping Nan; Yugui Niu; Xiuhua Wang; Qiang Li
Journal:  Onco Targets Ther       Date:  2019-08-26       Impact factor: 4.147

6.  DNA hypermethylation of sirtuin 1 (SIRT1) caused by betel quid chewing-a possible predictive biomarker for malignant transformation.

Authors:  Shajedul Islam; Osamu Uehara; Hirofumi Matsuoka; Yasuhiro Kuramitsu; Bhoj Raj Adhikari; Daichi Hiraki; Seiko Toraya; Asiri Jayawardena; Ichiro Saito; Malsantha Muthumala; Hiroki Nagayasu; Yoshihiro Abiko; Itsuo Chiba
Journal:  Clin Epigenetics       Date:  2020-01-13       Impact factor: 6.551

7.  Suppression of sirtuin 1 alleviates airway inflammation through mTOR‑mediated autophagy.

Authors:  Yuanyuan Wu; Wei Li; Yifan Hu; Yun Liu; Xiuzhen Sun
Journal:  Mol Med Rep       Date:  2020-07-13       Impact factor: 2.952

8.  Oncogenic role of MiR-130a in oral squamous cell carcinoma.

Authors:  Karthik Mallela; Swamy Shivananda; Kodaganur S Gopinath; Arun Kumar
Journal:  Sci Rep       Date:  2021-04-08       Impact factor: 4.379

9.  Noninvasive quantification of SIRT1 expression-activity and pharmacologic inhibition in a rat model of intracerebral glioma using 2-[18F]BzAHA PET/CT/MRI.

Authors:  Maxwell T Laws; Robin E Bonomi; David J Gelovani; Jeremy Llaniguez; Xin Lu; Thomas Mangner; Juri G Gelovani
Journal:  Neurooncol Adv       Date:  2020-01-16

Review 10.  Nicotinic-nAChR signaling mediates drug resistance in lung cancer.

Authors:  Wan-Li Cheng; Kuan-Yuan Chen; Kang-Yun Lee; Po-Hao Feng; Sheng-Ming Wu
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.